Blaubeuren-Sonderbuch, Germany

Kurt Rauchle


Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 54(Granted Patents)


Location History:

  • Blaubeuren, DE (1987)
  • Blaubeuren-Sonderbuch, DE (1985 - 1990)

Company Filing History:


Years Active: 1985-1990

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Kurt Rauchle

Introduction

Kurt Rauchle is a notable inventor based in Blaubeuren-Sonderbuch, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative therapeutic solutions. With a total of three patents to his name, Rauchle's work has had a considerable impact on the treatment of rheumatic diseases.

Latest Patents

Rauchle's latest patents include groundbreaking formulations that enhance the efficacy of existing medications. One of his notable inventions is the development of diethylene glycol monoester derivatives, which are derived from antirheumatically effective acids such as lonazolac and diclofenac. These novel compounds exhibit inflammation inhibitory properties that surpass those of their acid base forms. They can be produced through direct esterification without the elimination of water, making them suitable for combating diseases of the rheumatic complex. Another significant patent involves liquid diclofenac preparations, which are stable aqueous solutions containing a mixture of propylene glycol and polyethylene glycol. These solutions are designed to be relatively concentrated and may include local anesthetics like lidocaine, along with a reducing agent for stabilization.

Career Highlights

Kurt Rauchle is currently associated with Merckle GmbH, a prominent pharmaceutical company. His work at Merckle has allowed him to focus on innovative drug formulations that address complex medical conditions. His expertise in the field has contributed to the advancement of therapeutic options available to patients.

Collaborations

Throughout his career, Rauchle has collaborated with esteemed colleagues such as Gunter Metz and Otto Von Stetten. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of innovative solutions in the pharmaceutical industry.

Conclusion

Kurt Rauchle's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to innovation. His work continues to influence the development of effective treatments for rheumatic diseases, showcasing the importance of research and invention in improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…